Table 1.
Study | Duration (weeks) | Sample size | Mean age (years) | % Men | % White | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | Treatment | Varenicline | Placebo | Varenicline | Placebo | Varenicline | Placebo | Varenicline | Placebo | |||||
Anthenelli, 201324 | 52 | 12 | 256 | 269 | 45.4 | 47.1 | 37.9 | 36.8 | NA | NA | ||||
Bolliger, 201125 | 24 | 12 | 394 | 199 | 43.1 | 43.9 | 57.7 | 65.7 | 30.3 | 31.3 | ||||
Brandon, 201126 | 2.2 | 2.2 | 56 | 58 | 45.8 | 41.2 | 60.9 | 61.1 | 54.1 | 64.8 | ||||
Burstein, 200627 | 1.3 | 1.3 | 8 | 8 | 68.1 | 67.9 | 75 | 50 | 50 | 37.5 | ||||
Chengappa, 201466 | 24 | 12 | 31 | 29 | 45.7 | 46.2 | 29 | 34.5 | 64.5 | 72.4 | ||||
Cinciripini, 201328 | 24 | 12 | 86 | 106 | 43.8 | 45.2 | 61.6 | 63.2 | 58.1 | 71.7 | ||||
Ebbert, 201129 | 24 | 12 | 38 | 38 | 40.7 | 41 | 100 | 100 | 100 | 100 | ||||
Evins, 201430 | 64 | 40 | 40 | 47 | 51.4 | 45.7 | 60 | 66 | 75 | 72 | ||||
Faessel, 200931 | 2.6 | 2 | 14 | 7 | 15.4 | 15.4 | 57.1 | 57.1 | 85.7 | 71.4 | ||||
Fagerstrom, 201032 | 26 | 12 | 213 | 218 | 43.9 | 43.9 | 89 | 90 | 99 | 100 | ||||
Fatemi, 201333 | 12 | 12 | 6 | 9 | 40.4 | 41.4 | 83.3 | 77.8 | 50 | 88.9 | ||||
Garza, 201134 | 16 | 12 | 55 | 55 | 33.4 | 33.8 | 60 | 72.7 | 80 | 70.9 | ||||
Gonzales, 200635 | 52 | 12 | 352 | 344 | 42.5 | 42.6 | 50 | 54.1 | 79.5 | 76.2 | ||||
Gonzales, 201467 | 52 | 12 | 251 | 247 | 47.7 | 47.3 | 49.8 | 49.4 | 94.8 | 91.4 | ||||
Hughes, 201136 | 24 | 8 | 107 | 111 | 44 | 41.2 | 60.5 | 57.2 | 91.4 | 91.9 | ||||
Jorenby, 200637 | 52 | 12 | 344 | 341 | 44.6 | 42.3 | 55.2 | 58.1 | 85.5 | 85 | ||||
Litten, 201338 | 16 | 13 | 97 | 101 | 46 | 45 | 73.2 | 68.3 | 61.9 | 70.3 | ||||
McClure, 201339 | 5 | 5 | 54 | 50 | 45 | 43 | 40 | 59 | 32 | 36 | ||||
McKee, 200940 | 1.1 | 1 | 10 | 10 | 34.2 | 35.3 | 80 | 80 | 40 | 90 | ||||
Meszaros, 201341 | 12 | 8 | 5 | 5 | 42 | 44 | 80 | 60 | 40 | 60 | ||||
Mitchell, 201242 | 16 | 12 | 33 | 31 | 29 | 25 | 55 | 65 | 73 | 64 | ||||
Nakamura, 200743 | 52 | 12 | 156 | 154 | 40.1 | 39.9 | 79.2 | 76 | NA | NA | ||||
Niaura, 200844 | 40 | 12 | 160 | 160 | 41.5 | 42.1 | 50.3 | 53.5 | 93 | 88.4 | ||||
Nides, 200645 | 52 | 7 | 127 | 127 | 41.9 | 41.6 | 50.4 | 52 | 85.6 | 87.8 | ||||
Oncken, 200646 | 52 | 12 | 259 | 129 | 42.2 | 43 | 48.5 | 51.9 | 80.8 | 72.1 | ||||
Plebani, 201247 | 9 | 8 | 18 | 19 | NA | NA | 69.6 | 75 | 11 | 33 | ||||
Plebani, 201348 | 13 | 12 | 19 | 21 | 44.8 | 48.1 | 78.9 | 90.5 | 42.1 | 71.4 | ||||
Poling, 201049 | 12 | 11 | 13 | 18 | 36.5 | 34.4 | 84.6 | 77.8 | 46.2 | 72.2 | ||||
Rennard, 201250 | 24 | 12 | 493 | 166 | 43.9 | 43.2 | 60 | 59.6 | 68 | 68.1 | ||||
Rigotti, 201051 | 52 | 12 | 355 | 359 | 57 | 55.9 | 75.2 | 82.2 | 80.3 | 80.8 | ||||
Shim, 201252 | 8 | 8 | 60 | 60 | 39.9 | 39.9 | 38 | 45 | 0 | 0 | ||||
Stein, 201353 | 24 | 24 | 137 | 45 | 39.2 | 40.6 | 46 | 62.2 | 82.5 | 75.6 | ||||
Steinberg, 201154 | 24 | 12 | 40 | 39 | NA | NA | 60 | 59 | 77 | 67 | ||||
Tashkin, 201155 | 52 | 12 | 250 | 254 | 57.2 | 57.1 | 62.5 | 62.2 | 81.9 | 84.1 | ||||
Tonnesen, 201356 | 52 | 12 | 70 | 69 | 53.6 | 55.6 | 42.9 | 49.3 | NA | NA | ||||
Tonstad, 200657 | 52 | 12 | 603 | 607 | 45.4 | 45.3 | 50.2 | 48.3 | 96.7 | 97 | ||||
Tsai, 200758 | 24 | 12 | 126 | 124 | 39.7 | 40.9 | 84.9 | 92.7 | 0 | 0 | ||||
Wang, 200959 | 24 | 12 | 165 | 168 | 39 | 38.5 | 96.4 | 97 | 0 | 0 | ||||
Weiner, 201160 | 12 | 12 | 4 | 5 | NA | NA | NA | NA | NA | NA | ||||
Williams, 200761 | 53 | 52 | 251 | 126 | 48.2 | 46.6 | 50.6 | 48.4 | 86.9 | 92.1 | ||||
Williams, 201262 | 26 | 12 | 84 | 43 | 40.2 | 43 | 77.4 | 76.7 | 59.5 | 58.1 | ||||
Wong, 201263 | 52 | 12 | 151 | 135 | 51.9 | 53.3 | 55 | 50.4 | NA | NA | ||||
Zesiewicz, 201264 | 8 | 8 | 10 | 10 | 47.4 | 53.8 | 44 | 67 | NA | NA | ||||
Zhao, 201165 | 3.7 | 3 | 14 | 10 | 71 | 73 | 42.9 | 50 | 100 | 90 |
NA=not applicable.